Phenyl isocyanate → 1-[3-(1-Methyl-1H-pyrazolo[3,4-c]pyridin-4-ylethynyl)-phenyl]-3-phenyl-urea
Reaction equation
[CH3:1][N:2]1[C:6]2=[CH:7][N:8]=[CH:9][C:10]([C:11]#[C:12][C:13]3[CH:14]=[C:15]([NH2:19])[CH:16]=[CH:17][CH:18]=3)=[C:5]2[CH:4]=[N:3]1.[C:20]1([N:26]=[C:27]=[O:28])[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=1>C(Cl)Cl>[CH3:1][N:2]1[C:6]2=[CH:7][N:8]=[CH:9][C:10]([C:11]#[C:12][C:13]3[CH:14]=[C:15]([NH:19][C:27]([NH:26][C:20]4[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=4)=[O:28])[CH:16]=[CH:17][CH:18]=3)=[C:5]2[CH:4]=[N:3]1Participants
4
Procedure
In analogy to GP 5, 100 mg of 3-(1-methyl-1H-pyrazolo[3,4-c]pyridin-4-ylethynyl)-phenylamine (Intermediate 3.1, 0.26 mmol, 1 eq.) were treated with 31 μL phenyl isocyanate (0.29 mmol, 1.1 eq.) in 2.6 mL DCM at rt. Aqueous work-up followed by HPLC purification provided the target compound.
Workup
- customAqueous work-up followed by HPLC purification
- customprovided the target compound
Sources & evidence
- ORD record
- ord-f4cd5de3d3714402935930e21b829a77
- Source dataset
- uspto-grants-2013_07
- Patent number
- US08481539B2
Reaction notes
Loading…